Quick Takeaways
- T. Rowe Price Investment Management, Inc. filed SCHEDULE 13G for PRIME MEDICINE INC COMMON STOCK (PRME).
- Disclosed ownership: 5.3%.
- Date of event: 30 Sep 2025.
T. Rowe Price Investment Management, Inc. - 30 Sep 2025 SCHEDULE 13G Report for PRIME MEDICINE INC COMMON STOCK (PRME)
- Filing Manager
- T. Rowe Price Investment Management, Inc.
- Reporting Manager
- T. Rowe Price Investment Management, Inc.
- Security
- PRIME MEDICINE INC COMMON STOCK
- Symbol
- PRME
- Shares outstanding
- 174,282,170 shares
- Disclosed Ownership
- 9,236,955 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 12:18:25 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"T. Rowe Price Investment Management, Inc. disclosed 5.3% ownership in PRIME MEDICINE INC COMMON STOCK (PRME) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 12:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.3% | 9,236,955 | 9,236,955 | 0 | Ellen York | Vice President |